Alan Sharpe
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 3
- Co-authors
- Jill Walker (9 shared papers)David Carruthers (1 shared paper)Christine McHugh (1 shared paper)A.M. Riddle (2 shared papers)M. Ratcliffe (8 shared papers)Marietta Scott (8 shared papers)Paul Scorer (6 shared papers)Craig Barker (6 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (3 papers)Clinical Cancer Research (2 papers)Research in Veterinary Science (2 papers)Cancer Research (2 papers)
- Partner nations
- United KingdomUnited StatesSouth Korea
In The Last Decade
Alan Sharpe
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 117
- Oncology 418
- Cancer Research 231
- Pollution 132
- Environmental Engineering 163
- Health, Toxicology and Mutagenesis 150
Countries citing papers authored by Alan Sharpe
This map shows the geographic impact of Alan Sharpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Sharpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Sharpe more than expected).
Fields of papers citing papers by Alan Sharpe
This network shows the impact of papers produced by Alan Sharpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Sharpe. The network helps show where Alan Sharpe may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Sharpe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 240 | |
| 2 | 2017 | 240 | |
| 3 | 2003 | 193 | |
| 4 | 2016 | 123 | |
| 5 | 2018 | 46 | |
| 6 | 2009 | 43 | |
| 7 | 2011 | 40 | |
| 8 | Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group. | 1998 | 38 |
| 9 | 2016 | 35 | |
| 10 | 2019 | 33 | |
| 11 | 2015 | 29 | |
| 12 | 2004 | 27 | |
| 13 | 2016 | 25 | |
| 14 | 2012 | 25 | |
| 15 | 2012 | 23 | |
| 16 | 2019 | 21 | |
| 17 | 2016 | 19 | |
| 18 | 2016 | 18 | |
| 19 | 2016 | 17 | |
| 20 | 2014 | 15 |
About Alan Sharpe
Alan Sharpe is a scholar working on Oncology, Molecular Biology, Cancer Research, Pollution and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Cancer Genomics and Diagnostics (6 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers), Analytical chemistry methods development (3 papers), CAR-T cell therapy research (3 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers), Analytical Chemistry and Chromatography (2 papers) and Environmental Toxicology and Ecotoxicology (2 papers). The work is most often cited by research in Oncology (418 citations), Cancer Research (231 citations), Pollution (132 citations), Environmental Engineering (163 citations) and Health, Toxicology and Mutagenesis (150 citations). Alan Sharpe has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include Jill Walker, David Carruthers, Christine McHugh, A.M. Riddle, M. Ratcliffe, Marietta Scott, Paul Scorer, Craig Barker, Anita Midha and Marlon C. Rebelatto. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Research in Veterinary Science and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.